Social Acceptability of COVID-19 Vaccines in Pakistan

February 23, 2021 updated by: Jafir Hussain Shirazi, Islamia University of Bahawalpur

Social Acceptability of COVID-19 Vaccines in Pakistan: Fear and Social Trends

Social settings of Pakistan is unique in the sense that it is composed of multilingual, multicultural and different ethnicities. Also their believes and faiths are so unpredictable. It is therefore observed that this social phenomenon affects the acceptability of new things in this area. Polio vaccination has not worked so well in the past. Iodized salt acceptability has also been criticized in the last decades and is a matter of controversy till now. This behavior has also developed before the commencement of vaccination of COVID-19 in Pakistan, as there are many rumors and fears circulating via social media amongst Pakistan. What will be the acceptance rate for this vaccination, the time will decide.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
986

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Capital Territory
      • Islamabad, Capital Territory, Pakistan, 44000
        • Islamabad City
    • Punjab
      • Bahawalpur, Punjab, Pakistan, 63100
        • Bahawalpur Rural and Urban Areas
      • Faisalābad, Punjab, Pakistan, 38000
        • Faisalabad city
      • Lahore, Punjab, Pakistan, 54000
        • Lahore City

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

All residents of pakistan are eligible to be in included in the study regardless of their geo-location and residencey

Description

Inclusion Criteria:

  • Adult
  • Cooperative
  • Willing to participate in study
  • Pakistani citizen

Exclusion Criteria:

  • Minors
  • non-cooperative/unconconcious
  • non-citizen of Pakistan

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Islamabad Group
Individuals residing and surveyed in Islamabad
Other: Questionnaire
A structured questionnaire will be served to each participant of study after getting the verbal consent from him for inclusion into the study
Lahore Group
Individuals residing and surveyed in Lahore
Other: Questionnaire
A structured questionnaire will be served to each participant of study after getting the verbal consent from him for inclusion into the study
Faisalabad Group
Individuals residing and surveyed in Faisalabad
Other: Questionnaire
A structured questionnaire will be served to each participant of study after getting the verbal consent from him for inclusion into the study
Bahawalpur Group
Individuals residing and surveyed in Bahawalpur

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Demographics (Age)
Time Frame: Till 23 February 2021
This is a survey based study in which questionnaire based survey will be conducted. Respondents will be asked about their age, their response will be recorded.
Till 23 February 2021
Demographics (Weight)
Time Frame: Till 23 February 2021
This is a survey based study in which questionnaire based survey will be conducted. Respondents will be asked about their weight and their response will be recorded.
Till 23 February 2021
Demographics (Gender)
Time Frame: Till 23 February 2021
This is a survey based study in which questionnaire based survey will be conducted. Respondents will be asked about their gender and their response will be recorded.
Till 23 February 2021
Demographics (Education)
Time Frame: Till 23 February 2021
This is a survey based study in which questionnaire based survey will be conducted. Respondents will be asked about their level of education and their response will be recorded.
Till 23 February 2021
Demographics (Family set up)
Time Frame: Till 23 February 2021
This is a survey based study in which questionnaire based survey will be conducted. Respondents will be asked about their family set i.e. joint family or separate family and their response will be recorded.
Till 23 February 2021
Demographics (Residence)
Time Frame: Till 23 February 2021
This is a survey based study in which questionnaire based survey will be conducted. Respondents will be asked about their residence i.e. either in rural area or living in city and their response will be recorded.
Till 23 February 2021
Attitude, knowledge and behavior about COVID-19 Vaccine and its acceptance or rejection
Time Frame: Till 23 February 2021
As this is a survey based study in which questionnaire based survey will be conducted. Respondents will be asked about vaccines, knowledge about vaccines, about corona vaccine specifically, about efficacy of vaccines, about efficacy of COVID-19 vaccine. about acceptance or rejection of vaccine, if they will not have a shot of vaccine then reasons, if they will have shots then reason for vaccination. if they are fear off vaccines then their reasons
Till 23 February 2021

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Correlation of Age with a particular behavior
Time Frame: Till the end of February 2021
Statistical Analysis of raw data about age will be computed. Various age groups will be classified and arranged. Frequencies of these age groups will be calculated and will be analyzed about any relationship with a particular behavior about vaccination.
Till the end of February 2021
Correlation of Weight with a particular behavior
Time Frame: Till 23 February 2021
Statistical Analysis of raw data about age will be computed. Various age groups will be classified and arranged. Frequencies of these age groups will be calculated and will be analyzed about any relationship with a particular behavior about vaccination.
Till 23 February 2021
Correlation of Gender with a particular behavior
Time Frame: Till 23 February 2021
Statistical Analysis of raw data about age will be computed. Various age groups will be classified and arranged. Frequencies of these age groups will be calculated and will be analyzed about any relationship with a particular behavior about vaccination.
Till 23 February 2021
Correlation of Education level with a particular behavior
Time Frame: Till 23 February 2021
Statistical Analysis of raw data about age will be computed. Various age groups will be classified and arranged. Frequencies of these age groups will be calculated and will be analyzed about any relationship with a particular behavior about vaccination.
Till 23 February 2021
Correlation of Family set up with a particular behavior
Time Frame: Till 23 February 2021
Statistical Analysis of raw data about age will be computed. Various age groups will be classified and arranged. Frequencies of these age groups will be calculated and will be analyzed about any relationship with a particular behavior about vaccination.
Till 23 February 2021
Correlation of Residence with a particular behavior
Time Frame: Till 23 February 2021
Statistical Analysis of raw data about age will be computed. Various age groups will be classified and arranged. Frequencies of these age groups will be calculated and will be analyzed about any relationship with a particular behavior about vaccination.
Till 23 February 2021
Respondents Attitude, knowledge and behavior about COVID-19 Vaccine and its acceptance or rejection
Time Frame: Till 23 February 2021
Statistical Analysis of raw data about age will be computed. Various age groups will be classified and arranged. Frequencies of these age groups will be calculated and will be analyzed about any relationship with a particular behavior about vaccination. t-Test will be applied to observe any statistically significant difference between different co-variates
Till 23 February 2021

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Islamia University of Bahawalpur

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Jafir Shirazi, PhD, The Islamia University of Bahawalpur
  • Study Director: Anam Sharmeen, M. Phil, The Islamia University of Bahawalpur
  • Study Chair: Asfa Akbar, M. Phil, The Islamia University of Bahawalpur
  • Study Chair: Fouzia Akbar, M.Phil, The Islamia University of Bahawalpur

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 23, 2021

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
February 23, 2021

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
February 23, 2021

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
January 22, 2021

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 26, 2021

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
January 27, 2021

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
February 24, 2021

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 23, 2021

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
February 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • Living amongst the fear

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Social Acceptance, Social Anxiety

Clinical Trials on Questionnaire

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings